Host Peg Crowley-Nowick, PhD, MBA, Founder & President of Zipher Medical Affairs and Murial Siadak, PAC, spotlight the ever-increasing value and impact of insights on product strategy, positioning, and tactics.
An effective program management system with well-designed project trackers, dashboards and project management support can accelerate your launch strategy.
Drs. Crowley-Nowick and Keir set the stage for a successful launch as they consider the key components of a MA Team and their contributions on the road to launch and beyond, from the formation and training of the Medical Science Liaison Team (MSLs) to the early inclusion of Medical Information, to developing best practices for Scientific Communications while also engaging with Patient Advocacy groups as part of the planning process.
Starting from the clinical trials and ending with meeting the regulatory demands across various countries, bringing a product to market successfully has become increasingly difficult. Therefore, it is critical that an overall launch strategy is established and executed.
Measuring the impact of the Medical Affairs (MA) organization is not as straightforward as it is for other functions (e.g., increase in revenue or market share for Commercial) and remains a challenge for most pharmaceutical companies today.
Zipher’s Medical Affairs unscripted features Dr. Zhen Su, an industry expert with over 20 years of experience and currently the Senior Vice President and Global Head of the Oncology Franchise for Merck, KGaA, Darmstadt, Germany to discuss how to develop the internal value of Medical Affairs as a strategic equal, improve cross-functional collaboration, and how to adapt to the virtual environment in this pandemic era and beyond.
Dr. Peg Crowley-Nowick, Founder & President of Zipher Medical Affairs is joined by Zipher’s own Julie Cahill, M.D., Vice President of Consulting and Medical Director Services to continue the conversation from the episode "Data Generation | The Intersection Between Medical Affairs and Clinical Development" by expanding further on the need to identify data gaps and how organizations can work together to consider the full scope of research that can be used to fill those gaps.
As the Zipher Medical Affairs unscripted podcast series continues to distinguish Medical Affairs as one of the major pillars of biopharmaceutical organizations, Dr. Peg Crowley-Nowick, Founder & President of Zipher Medical Affairs hosts Dr. Adam Schayowitz, an industry veteran and current Vice President and Medicine Team Lead at Pfizer, to discuss the intersection between Medical Affairs (medical) and Clinical Development (development) with regards to data generation as medical continues its evolution as the third pillar in industry.
This episode of Zipher’s Medical Affairs unscripted features Randi Goeckeler, an industry expert with over 25 years of experience and most recently the Executive Director of Global Stakeholder Relations at Allergan, who discusses how to build an integrated, strategic stakeholder relations program to accelerate availability of treatments for patients and ultimately help them have better outcomes.
Don't miss Zipher's upcoming white paper, "Defining the Course and Navigating the Finish Line."
